|

Melatonin on Anxiety and Sleep Quality in Adults Undergoing Coronary Artery Bypass Graft Surgery

RECRUITINGN/ASponsored by Ain Shams University
Actively Recruiting
PhaseN/A
SponsorAin Shams University
Started2024-02-01
Est. completion2024-12-01
Eligibility
Age40 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06237556

Summary

The objective of this study is to evaluate the effect of melatonin on post operative sleeping quality, anxiety, and post-operative opioid requirements in adults post coronary artery bypass graft (CABG) surgery.

Eligibility

Age: 40 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age from 40-60 years.
* Both sexes.
* Patients undergoing standard on-pump CABG with the same technique by the same surgical team.

Exclusion Criteria:

* Refusal of procedure or participation in the study by patients.
* Patients with known history of allergy to one of study drugs
* Patients taking psychiatric medications, CNS depressants, and hypnotic drugs.
* Patients with neurological disorders stroke, intracranial hemorrhage and surgery.
* Patients with a history of suffering from any sleep disorder.
* Severe circulatory or respiratory disease.
* Patients with obstructive sleep apnea.
* Cognitive or psychiatric illness that leads to inability to cooperate, speak or provide informed consent

Conditions5

AnxietyCoronary Artery Bypass GraftHeart DiseaseMelatoninSleep Quality

Browse More Trials

Heart Disease trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.